Plexus Corp. (NASDAQ:PLXS) CAO Angelo Michael Ninivaggi, Jr. sold 3,061 shares of Plexus stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $73.22, for a total value of $224,126.42. Following the transaction, the chief accounting officer now directly owns 32,657 shares in the company, valued at $2,391,145.54. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Shares of PLXS opened at $74.29 on Friday. The firm has a market capitalization of $2.17 billion, a P/E ratio of 19.10 and a beta of 1.05. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.93 and a current ratio of 1.72. The stock has a 50 day moving average price of $68.27 and a two-hundred day moving average price of $65.17. Plexus Corp. has a 52 week low of $35.16 and a 52 week high of $86.53.

Plexus (NASDAQ:PLXS) last released its earnings results on Wednesday, July 22nd. The technology company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.45. Plexus had a return on equity of 12.41% and a net margin of 3.55%. The company had revenue of $857.39 million during the quarter, compared to analyst estimates of $801.94 million. On average, equities analysts forecast that Plexus Corp. will post 3.93 earnings per share for the current year.

A number of research analysts have recently issued reports on PLXS shares. Needham & Company LLC boosted their price objective on Plexus from $67.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, July 24th. TheStreet raised Plexus from a “c+” rating to a “b” rating in a research note on Wednesday, July 22nd. Stifel Nicolaus boosted their target price on Plexus from $60.00 to $80.00 and gave the company a “hold” rating in a research report on Friday, July 24th. Zacks Investment Research raised Plexus from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a research report on Monday, July 27th. Finally, ValuEngine lowered Plexus from a “hold” rating to a “sell” rating in a research report on Thursday, July 23rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $80.67.

A number of institutional investors have recently bought and sold shares of PLXS. Norges Bank purchased a new position in Plexus in the fourth quarter valued at approximately $32,762,000. Deutsche Bank AG lifted its stake in Plexus by 1,340.5% in the first quarter. Deutsche Bank AG now owns 290,904 shares of the technology company’s stock valued at $15,871,000 after purchasing an additional 270,709 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Plexus by 38.0% in the first quarter. Victory Capital Management Inc. now owns 849,182 shares of the technology company’s stock valued at $46,331,000 after purchasing an additional 233,635 shares during the last quarter. Channing Capital Management LLC purchased a new stake in shares of Plexus during the first quarter worth $10,726,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Plexus during the second quarter worth $9,371,000. Institutional investors and hedge funds own 95.26% of the company’s stock.

About Plexus

Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services. The company provides its solutions to companies in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense sectors.

Further Reading: Secondary Public Offerings

Insider Buying and Selling by Quarter for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.